Today: 21 May 2026
Browse Category

NASDAQ:LITE 6 February 2026 - 28 February 2026

Lumentum stock price rebounds after Thursday slide as Form 144 sale notice hits tape

Lumentum stock price rebounds after Thursday slide as Form 144 sale notice hits tape

Lumentum shares rose 3.5% to $700.91 Friday, rebounding after a 6.4% drop Thursday, with heavy trading and wide price swings. A new SEC Form 144 filing showed Morgan Stanley Smith Barney plans to sell 5,302 shares worth about $3.66 million. Investors are watching management’s upcoming conference appearances for signals on AI data-center demand. The S&P 500 and Nasdaq both fell on the day.
28 February 2026
Lumentum stock hits fresh high as traders lean into AI optics demand

Lumentum stock hits fresh high as traders lean into AI optics demand

Lumentum shares hit $688.27 before easing to $674.73, up about 1.1% in late-morning New York trading Tuesday, with volume at 4.5 million shares. The move follows strong demand for optical circuit switches and co-packaged optics tied to AI data centers. Investors await management’s investor briefing at OFC on March 17. Peers traded mixed, while the broader semiconductor ETF slipped 0.7%.
Lumentum stock jumps in Friday trade as AI infrastructure rotation keeps LITE in focus

Lumentum stock jumps in Friday trade as AI infrastructure rotation keeps LITE in focus

Lumentum shares jumped 4.3% to $662.99 Friday morning, hitting a new intraday high amid heavy trading. A regulatory filing showed Executive Vice President Vincent Retort sold 3,441 shares on Feb. 17 under a pre-set plan. Investors have rotated into AI infrastructure stocks, boosting optics and networking names. Lumentum’s recent earnings beat and raised outlook have fueled the rally.
20 February 2026
Lumentum stock: Insider sale near $600 hits tape as Wall Street heads into Presidents Day break

Lumentum stock: Insider sale near $600 hits tape as Wall Street heads into Presidents Day break

Lumentum director Penny Herscher sold 4,000 shares for about $2.39 million, according to an SEC filing. The stock closed down 3.6% at $562.74 on Friday after hitting $603.83 Thursday. U.S. markets are closed Monday for Presidents Day, with trading set to resume Tuesday. Another executive, Vincent Retort, also disclosed a large sale under a pre-arranged plan.
16 February 2026
Lumentum stock price drops after hours as investors eye Susquehanna, Morgan Stanley talks

Lumentum stock price drops after hours as investors eye Susquehanna, Morgan Stanley talks

Lumentum Holdings shares dropped 2.8% to $561.13 in after-hours trading Tuesday, following a volatile session with a $48 range and 4.8 million shares traded. The decline comes ahead of management appearances at Susquehanna’s tech conference on Feb. 26 and Morgan Stanley’s event on March 2. Coherent fell 5.9%, Broadcom 1.0%, and Marvell Technology 0.4% in related trading.
11 February 2026
Lumentum stock price drops as rally cools — here’s what traders watch next

Lumentum stock price drops as rally cools — here’s what traders watch next

Lumentum shares fell 2.4% to $563.33 Tuesday morning after a strong prior session, swinging between $531 and $579 as major indexes edged up. The drop follows a recent rally tied to AI and cloud data-center spending. Last week, Lumentum reported Q2 revenue of $665.5 million and forecast Q3 revenue up to $830 million. Management will appear at tech conferences on Feb. 26 and March 2.
10 February 2026
Lumentum stock jumps 7% as AI optics rally resumes, putting focus back on convertible-note risk

Lumentum stock jumps 7% as AI optics rally resumes, putting focus back on convertible-note risk

Lumentum shares jumped 7.3% to $592.50 in late-morning trading Monday, extending last week’s gains after the company forecast strong demand for AI data-center optics. A recent SEC filing warned that rising share prices have triggered early conversion eligibility for its convertible notes, raising liquidity concerns if holders act quickly.
Lumentum (LITE) stock jumps after-hours as AI optics trade stretches into next week

Lumentum (LITE) stock jumps after-hours as AI optics trade stretches into next week

Lumentum Holdings shares jumped 9.3% to $551.99 in after-hours trading Friday after reporting fiscal Q2 revenue of $665.5 million and forecasting Q3 revenue of $780–$830 million. Analysts raised price targets following the upbeat outlook. A Form 144 filing disclosed a planned sale of 4,849 shares. Trading volume reached about 6.7 million shares.
Lumentum stock jumps nearly 8% as AI capex wave lifts optics names into the weekend

Lumentum stock jumps nearly 8% as AI capex wave lifts optics names into the weekend

Lumentum Holdings shares surged 8% to $544.68 Friday after reporting fiscal Q2 revenue of $665.5 million and a backlog topping $400 million for optical circuit switches. The company expects Q3 revenue between $780 million and $830 million. Traders cited strong AI-driven demand but flagged risks if cloud customers pause orders. Lumentum will brief investors at the OFC conference on March 17.
Lumentum stock price rises again as AI optics backlog keeps Wall Street lifting targets

Lumentum stock price rises again as AI optics backlog keeps Wall Street lifting targets

Lumentum Holdings shares rose 3.7% to $523.28 Friday after reporting a 65% jump in fiscal Q2 revenue to $665.5 million and forecasting March-quarter revenue of $780–$830 million. The company’s optical-circuit-switch backlog now exceeds $400 million, with a major co-packaged optics order due in 2027. Analysts at Citi, Needham, and B. Riley raised price targets, citing strong AI-related demand.
6 February 2026
Lumentum stock price jumps after hours as AI optics orders keep NASDAQ:LITE in play

Lumentum stock price jumps after hours as AI optics orders keep NASDAQ:LITE in play

Lumentum Holdings shares jumped 8.4% to $504.42 in after-hours trading Thursday after reporting fiscal Q2 revenue of $665.5 million and GAAP earnings of $0.89 per share. The company disclosed an optical circuit switch backlog “well beyond $400 million” and a new co-packaged optics order for delivery in early 2027. Trading volume hit 8.5 million shares. Investors await further guidance at Lumentum’s March 17 briefing.
1 2 3 4 7

Stock Market Today

  • Teradyne, Kulicke and Soffa, Impinj, Microchip, IPG Photonics Stocks Slide on U.S.-China Semiconductor Summit Outcome
    May 21, 2026, 2:58 AM EDT. Shares of Teradyne, Kulicke and Soffa, Impinj, Microchip Technology, and IPG Photonics dropped sharply following the U.S.-China summit, which ended without key breakthroughs on semiconductor exports. Expectations for U.S. approval of Nvidia's H200 chip shipments to China were unmet, disappointing investors. U.S. Trade Representative Jamieson Greer indicated semiconductors were not a negotiation focus, dampening near-term optimism. Despite the sell-off, IPG Photonics' stock, known for volatility, remains down significantly from its 52-week high but has gained 34.3% year-to-date. Market reactions highlight cautious sentiment amid geopolitical tensions, with analysts skeptical about swift comprehensive deals due to national security concerns.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Go toTop